C Marzorati
Overview
Explore the profile of C Marzorati including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Apolone G, Costantini M, Caselli L, Bos N, Caraceni A, Ciliberto G, et al.
BMC Public Health
. 2024 Dec;
24(1):3517.
PMID: 39696103
Background: European cancer programmes and policies lack a unified health-related quality of life (HRQoL) assessment tool. The European oncology quality of life toolkit (EUonQoL-Kit) is a novel set of HRQoL...
2.
Masiero M, Spada G, Fragale E, Pezzolato M, Munzone E, Sanchini V, et al.
Support Care Cancer
. 2024 Jun;
32(7):458.
PMID: 38916761
Purpose: Adherence to oral anticancer treatments (OATs) is a critical issue in metastatic breast cancer (MBC) to enhance survivorship and quality of life. The study is aimed to analyze the...
3.
Pezzolato M, Spada G, Fragale E, Cutica I, Masiero M, Marzorati C, et al.
Patient Prefer Adherence
. 2023 Dec;
17:3461-3473.
PMID: 38143947
Purpose: An interplay of clinical and psychosocial variables affects breast cancer patients' experiences and clinical trajectories. Several studies investigated the role of socio-demographic, clinical, and psychosocial factors in predicting relevant...
4.
Karademas E, Roziner I, Simos P, Mazzocco K, Pat-Horenczyk R, Sousa B, et al.
Psychol Health
. 2023 Apr;
40(1):141-154.
PMID: 37101374
Objective: This study aimed to examine whether self-efficacy to cope with cancer changes over time in patients with breast cancer and whether these potential changes are similar across patients. It...
5.
Karademas E, Simos P, Pat-Horenczyk R, Roziner I, Mazzocco K, Sousa B, et al.
J Clin Psychol Med Settings
. 2022 Apr;
30(1):119-128.
PMID: 35488971
The role of self-efficacy to cope with breast cancer as a mediator and/or moderator in the relationship of trait resilience to quality of life and psychological symptoms was examined in...
6.
Karademas E, Roziner I, Mazzocco K, Pat-Horenczyk R, Sousa B, Oliveira-Maia A, et al.
Psychol Health
. 2022 Feb;
38(12):1635-1648.
PMID: 35147473
Objective: The aim of this study was to examine the longitudinal impact of self-efficacy to cope with cancer on the cancer-related coping reactions of breast cancer patients and vice versa....
7.
Ferrarese C, Perego M, Marzorati C, Bianchi G, Frigo M, Pecora N, et al.
Ital J Neurol Sci
. 1996 Apr;
17(2):141-5.
PMID: 8797068
Recent experimental evidence has suggested that peripheral benzodiazepine receptors (PBR) may play a role in epilepsy and antiepileptic drug action. Since PBR are also present in circulating lymphocytes, and may...
8.
Ferrarese C, Marzorati C, Perego M, Bianchi G, Cavarretta R, Pierpaoli C, et al.
Neuropharmacology
. 1995 Apr;
34(4):427-31.
PMID: 7566474
Anticonvulsant drugs, such as carbamazepine, may exert some of their effects through peripheral benzodiazepine receptors (PBR), which are present in glial cells and regulate the synthesis of neurosteroids. PBR have...
9.
Ferrarese C, Appollonio I, Bianchi G, Frigo M, Marzorati C, Pecora N, et al.
Psychoneuroendocrinology
. 1993 Jan;
18(1):3-22.
PMID: 8386386
This review summarizes the evidence available on the involvement in stress of different classes of benzodiazepine receptors and their putative endogenous ligand, diazepam binding inhibitor (DBI), with particular reference to...
10.
Berkovich A, Ferrarese C, Cavaletti G, Alho H, Marzorati C, Bianchi G, et al.
Life Sci
. 1993 Jan;
52(15):1265-77.
PMID: 8385252
High-affinity binding sites for the isoquinoline carboxamide PK 11195 and 4'-chlorodiazepam (4'CD) in human lymphocytes are recognized by two putative endogenous ligands: diazepam binding inhibitor (DBI) and protoporphyrin IX. We...